Chemotype Cbd Dominant

CBD-dominant chemotypes represent cannabis plants bred or selected to express cannabidiol (CBD) as the primary cannabinoid, typically with THC levels below 0.3% in jurisdictions with legal thresholds. These plants are characterized by genetic expression patterns that favor CBDA synthase activity over THCA synthase, resulting in high CBD content upon decarboxylation. Breeders working in this category often cross high-CBD cultivars with stable genetics to maintain consistent cannabinoid ratios across generations. CBD-dominant plants are commonly associated with the therapeutic research community and are used extensively in breeding programs targeting non-intoxicating cannabis products. Terpene profiles in these chemotypes vary widely and are independent of CBD expression, allowing breeders to combine CBD dominance with diverse aromatic characteristics.

Breeders use CBD-dominant genetics as foundational material for creating balanced 1:1 CBD:THC ratios or pure CBD cultivars for research and commercial purposes. Understanding and stabilizing the genetic markers controlling CBD synthase expression is central to developing consistent, high-CBD cultivars across multiple generations.